FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Cerus Receives FDA Approval for Use of the INTERCEPT Blood System for Platelets Suspended in 100% Plasma
March 16, 2016
Cerus Announces the Inclusion of Pathogen Reduction Technology in FDA’s Revised Guidance Document on Bacterial Safety Standards for Platelets
March 15, 2016
Blood Centers of America Selects Cerus as its Supply Partner for Pathogen Reduction Technology
March 09, 2016
Biotechnology Equities Update -- Cerus, Seattle Genetics, Sangamo Biosciences, and ImmunoGen
February 12, 2016
category Publishing & Media
Cerus Enters Into Agreement With Banco de Sangre de Servicios Mutuos for the Use of INTERCEPT Platelets and Plasma in Puerto Rico to Sustain Blood Supply During Zika Epidemic
March 03, 2016
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here